NAMA Organizational Meeting Monday, October 8th, 7 P.M.

NAMA Organizational Meeting
Monday, October 8th, 7 P.M.

Chairs
Jo Sotheran, NAMA Board of Directors (Treasurer)
Joycelyn Woods, NAMA Board of Directors (President)
Joyce looks on as everyone gets ready...
As meeting starts Joycelyn Woods looks on over the shoulders of Tony Scro (NAMA Grievance Coordinator), James DePasquale (Long Island NAMA) and Donna Schoen (LIJ Patient Committee).
Jo talks about the NAMA chapters
Jo Sotheran introduces the reasons for discussing the relationship between the chapters and national NAMA. A more formal relationship needs to be developed however it must not interfere with grassroots advocacy. “What do you expect from NAMA?” she asks the chapters. Howard Lotsof (NAMA), Joe Neuberger (Delaware NAMA), Rokki Baker (NAMA & NAMA NorCal) and Maureen Begley (Arizona NAMA) listen to the issues.
Jo discusses the issues
Discussing chapter issues Jo Sotheran prepares to ask them about their advocacy work while Walter Ginter (NAMA) reminds the chapters how important is it to keep the grassroots aspects of methadone advocacy as Gary Nessenbaum (WAMM) looks on.
John talks Texas!
John Finger (TexNAMA and NAMA Regional Director of Southwest) reminds the group that it is the sense of belonging to a community that grassroots advocacy can bring to methadone treatment. Barbara Finger (TexNAMA and NAMA Board of Directors) takes notes.
Everyone listens to Joyce!

Carmen Pearman (The MAG), Judith Ostergard (AMMO), Norma Alexander (NAMA), Howard Lotsof (NAMA) and Joe Neuberger (Delaware NAMA) listen intently to discussions (right to left).

Carmen and Judith listen to the discussion
Carmen Pearman (The MAG) and Judith Ostergard (AMMO) listen to the comments from other chapterdiscussing their issues.
Donna What do you say?
Donna Schoen (LIJ Patient Committee) tells the group about her success at Nassau County Jail while Tony Scro (NAMA) and James DePasquale (Long Island NAMA) look on.
James joins in the discussion

James DePasquale (Long Island NAMA) talks about chapter activities while Jo Sotheran (NAMA), Walter Ginter (NAMA), Gary Nessenbaum (WAMM) and Tony Scro (NAMA Grievance Coordinator) listen.

Similar Posts

  • Federal Regulations

    Admin 10/06/2022

    Education Series Number 10 June 2004 The New Federal Regulations What Do They Mean for Patients? Methadone treatment in the U.S. is changing before our eyes. Some of this change has been rapid; some of it will take years or decades. Some patients have heard about new federal regulations, including an end to automatic dose…

  • Take Home Regulation Page 4098

    Admin 05/06/2021

    Page 4098 Federal Register Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i) Unsupervised or “take-home” use. To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements. (1)…

  • The National Methadone Conference

    Admin 03/14/2023

    Sponsored by American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Saturday, April 12, 2003 Pre-Conference Session  NAMA offers special thanks to Mallinckrodt. We also wish to thank Haworth Press, Vista Pharmaceuticals, Bendiner Labs, NIDA, and CSAT without whose support the first Certified Methadone Advocate (CMA) Training Course would not…

  • NAMA wishes to thank the National Institute on Drug Abuse

    Admin 07/19/2022

    NAMA wishes to thank the National Institute on Drug Abuse (NIDA) and the Center for Substance Abuse Treatment (CSAT) for their Support of Certified Methadone Advocate Training at the 2003 AATOD Conference in Washington DC. NAMA wishes to offer special thanks to Mallinckrodt  and American Association for the Treatment of Opioid Dependence (AATOD).

  • Exceptional Advocates

    Admin 12/02/2021

    The Board of Directors decided that the organization needed some mechanism to recognize NAMA chapters and other advocates who have done something that is exceptional. Thus it was decided that when their was an instance in which an advocate or individual took on a situation that was challenging and displayed exceptional skill in confronting it…

  • Drug Court Fact Sheet

    Admin 01/29/2022

    Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence. Overview Drug Courts are being confronted with increasing numbers of opiate dependent offenders. This Fact Sheet is intended to dispel misperceptions and educate practitioners about the efficacy of medication assisted treatment. Opioid dependence is a devastating reality and a treatable disease. According to…